Interim Buprenorphine vs. Waiting List for Opioid Dependence | Zendy

Stacey C. Sigmon | Zendy; Taylor A. Ochalek | Zendy; Andrew C. Meyer | Zendy; Bryce Hruska | Zendy; Sarah H. Heil | Zendy; Gary J. Badger | Zendy; Gail L. Rose | Zendy; John R. Brooklyn | Zendy; Robert P. Schwartz | Zendy; Brent A. Moore | Zendy; Stephen T. Higgins | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Interim Buprenorphine vs. Waiting List for Opioid Dependence

Author(s) -

Stacey C. Sigmon,

Taylor A. Ochalek,

Andrew C. Meyer,

Bryce Hruska,

Sarah H. Heil,

Gary J. Badger,

Gail L. Rose,

John R. Brooklyn,

Robert P. Schwartz,

Brent A. Moore,

Stephen T. Higgins

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmc1610047

Subject(s) - buprenorphine , medicine , interim , opioid , waiting list , anesthesia , emergency medicine , receptor , archaeology , history , transplantation

In 50 opioid users on a waiting list for maintenance treatment, those assigned to interim treatment with buprenorphine submitted a higher percentage of urine specimens that were negative for illicit opioids than those in the control group at 4 weeks (88% vs. 0%), 8 weeks (84% vs. 0%), and 12 weeks (68% vs. 0%).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research